Skip to content
Osel Devices logo

Osel Devices

OSELDEVICE NSE
₹366.95 No trade today
View as Markdown
MCP
Close 4 Nov 2026 ₹366.95 −304.60 −45.4% 1Y
Start ₹671.55

Key Fundamentals

SMEHealthcare Equipment & SuppliesHealthcare

Price-based figures as of · TTM

ROCE
24.40%
Debt to Equity
0.49
EPS (TTM)
—
Book Value
₹114.29
Market Cap
—
P/E (TTM)
—
P/B
3.21
ROE
19.60%
Dividend Yield
0.27%
EBITDA
₹55.20 Cr
52W High
₹835.00
52W Low
₹320.00
Volume
0

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

47 Average

Data confidence 84/100

Category scores

Quality
66
Strong
Returns, margins, earnings quality 22% weight
Valuation
48
Average
Cheap vs sector & own history 24% weight
Growth
99
Strong
Sales & profit trajectory 9% weight
Financial Health
38
Weak
Solvency, leverage, coverage 9% weight
Momentum
16
Poor
Trend strength, vol-adjusted 12% weight
Ownership
33
Poor
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company has delivered good profit growth of 84.7% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 26.4%

Weaknesses

1
  • Though the company is reporting repeated profits, it is not paying out dividend

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBearish766
OscillatorsBullish162
Moving AveragesStrong Bearish604

Key readings

RSI (14)
53.73
Neutral
MACD (12,26,9)
−5.26
Bullish
SMA (50)
368.47
Bearish
SMA (200)
457.54
Bearish

As of

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
5Y+38.74%
3Y+52.88%
1Y+57.53%

Net profit

Net profit growth by window
5Y+96.10%
3Y+79.67%
1Y+45.00%

Operating cash flow

Operating cash flow growth by window
5YOutflow widened by ₹17 Cr
3YOutflow widened by ₹9 Cr
1YOutflow narrowed by ₹49 Cr

Operating margin· change in pp

Operating margin growth by window
5Y+12.83 pp
3Y+7.11 pp
1Y+0.35 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2021₹57.00 Cr
Mar 2022₹65.00 Cr
Mar 2023₹82.00 Cr
Mar 2024₹132 Cr
Mar 2025₹186 Cr
Mar 2026₹293 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2021₹1.00 Cr
Mar 2022₹2.00 Cr
Mar 2023₹5.00 Cr
Mar 2024₹13.00 Cr
Mar 2025₹20.00 Cr
Mar 2026₹29.00 Cr

Half-yearly Results

₹ Cr
OSELDEVICE half-yearly results, ₹ crore
Particulars Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
51
82
87
99
147
146
Expenses
42
68
74
79
122
117
Operating Profit
9
14
13
20
25
29
OPM %
17%
17%
15%
20%
17%
20%
Other Income
0
0
0
0
0
2
Interest
1
2
2
2
4
6
Depreciation
0
0
0
1
1
1
PBT
7
12
11
18
20
24
Tax %
26%
35%
29%
32%
26%
41%
Net Profit
5
8
8
12
15
14
EPS (₹)
4.3
6.7
4.97
7.46
8.58
7.95

Profit & Loss

₹ Cr
OSELDEVICE profit and loss, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
57
65
82
132
186
293
Expenses
55
61
73
110
153
239
Operating Profit
3
4
9
22
33
53
OPM %
4.9%
7%
11%
17%
18%
18%
Other Income
0
0
0
0
0
2
Interest
0
1
1
3
3
10
Depreciation
1
1
1
1
1
1
PBT
2
3
7
19
29
44
Tax %
33%
29%
33%
32%
31%
34%
Net Profit
1
2
5
13
20
29
EPS (₹)
1.62
1.84
4.05
10.99
12.43
16.53
Div. Payout %
0%
0%
0%
0%
0%
0%

Balance Sheet

₹ Cr
OSELDEVICE balance sheet, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
1
2
2
12
16
18
Reserves
4
6
10
14
92
173
Borrowings
10
9
18
25
50
94
Other Liabilities
8
17
19
48
40
52
Total Liabilities
23
33
49
99
198
338
Fixed Assets
6
5
7
18
17
28
CWIP
0
0
0
0
0
2
Investments
0
0
0
0
0
48
Other Assets
17
28
42
80
180
261
Total Assets
23
33
49
99
198
338

Cash Flow

₹ Cr
OSELDEVICE cash flow, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
−3
3
−11
13
−69
−20
Investing
0
0
−2
−13
−11
−76
Financing
5
−2
8
4
83
89
Net Cash Flow
2
1
−4
4
4
−7
Free Cash Flow
−3
2
−12
0
−69
−33
CFO/EBITDA
−106
72
−113
67
−188
−22

Ratios

OSELDEVICE financial ratios, annual
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
45
63
57
73
128
134
Inventory Days
28
63
94
91
104
94
Days Payable
37
94
84
130
77
56
Cash Conversion Cycle
36
33
67
35
156
172
Working Capital Days
−12
−7
27
38
139
108
ROCE %
—
26%
35%
54%
31%
24%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Osel Devices insights

60 extracted metrics across FY21–FY26.

Shareholding Pattern

As of Sep 2026

  • Promoters 64.84%
  • Public 24.87%
  • Others 6.84%
  • DIIs 3.32%
  • FIIs 0.12%

No promoter shares pledged as of 14 Oct 2026

Change since Jun 2026

Documents

Frequently Asked Questions about Osel Devices

What does OSEL Devices Ltd do?
Founded in 2006, Osel Devices Limited manufactures LED display systems and hearing aids.
Where is OSEL Devices Ltd (OSELDEVICE) listed?
OSEL Devices Ltd trades as OSELDEVICE on the NSE.
Which sector does OSEL Devices Ltd belong to?
OSEL Devices Ltd is classified under the Healthcare sector, in the Medical Equipment industry.
What is the 52-week high and low of OSEL Devices Ltd?
Over the last 52 weeks OSEL Devices Ltd has traded between ₹320 and ₹835 as of 4 Nov 2026.
Does OSEL Devices Ltd pay dividends?
OSEL Devices Ltd has a dividend yield of 0.27%.
What is the Return on Equity (ROE) of OSEL Devices Ltd?
OSEL Devices Ltd reported a return on equity of 19.60%. Its debt-to-equity ratio is 0.49.

Company Information

Founded in 2006, Osel Devices Limited manufactures LED display systems and hearing aids.

Website oseldevices.com
Listed 24 Sep 2024
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/OSELDEVICE.md for OSEL Devices Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Healthcare Equipment stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month